Skip to main content
. 2009 May 15;8:28. doi: 10.1186/1476-4598-8-28

Figure 4.

Figure 4

Function and mRNA expression of P-glycoprotein after inhibitor treatment. (A) Doxorubicin efflux was measured after inhibitor treatment. Only C-4 (P-glycoprotein inhibitor) treatment inhibited doxorubicin efflux significantly. (Bcl-2 inh: Bcl-2 inhibitor) (B) mRNA expression of P-glycoprotein was measured by RT-PCR. All inhibitors did not change mRNA expression of P-glycoprotein. mRNA expression of P-glycoprotein of each inhibitor treatment was divided by mRNA expression of DMSO control. (Bcl-2 inh: Bcl-2 inhibitor).